Pharmaceuticals

China, US and Japan Drugs for Treatment of Breast Cancer Industry 2016 Deep Market Research Report

  • QYR605986
  • 135 Pages
  • June 2016
  • Pharmaceuticals
The global Drugs for Treatment of Breast Cancer market was valued at USD 142 Billion in 2015, which sales in China USD 4.68 Billion, in US 37 Billion, in Japan 6.82 Billion. And is projected to reach USD 210 Billion global by 2021, at a CAGR of 8.14% between 2016 and 2021. Ibrance, the drug star of Pfizer will become a major growth point, which sales USD 7.23 billion in US. Ibrance enter the market in 2015. The market is projected witness significant growth in the coming years, owing to the aging population increase, increased incidence and development of new drugs

This report studies Drugs for Treatment of Breast Cancer in China, US and Japan market, focuses on price, sales, market share and revenue of each type in China, US and Japan.

Split by product types, with sales, revenue, market share and price of each type, as well as the types and each type price of key manufacturers, through interviewing key manufacturers, in 2015 and 2016, covering
Faslodex
Hercepti
Perjeta
Kadcyla
Afinitor
Avastin
Tamoxifen Citrate Tablets
Exemestane Tablets
Letrozol Tablets
Capecitabine Tablets
Ibrance

Split by manufacturers, this report focuses on the sales, price of each type, average price of Treatment of Breast Cancer, revenue and market share, for each manufacturer in 2015 and 2016. Top players, covering
Roche
Pfizer
Novartis
AstraZeneca
Yangtze River Pharmaceutical Group
FORWARD
NT Pharma
Jiang Su Heng Rui Medicine


Split by regions, this report focuses on the sales (consumption), production, import and export of Drugs for Treatment of Non-small-Cell Lung Cancer in US, Western Europe, Japan and China, from 2011 to 2020 (forecast), covering
Established markets
Europe
Emerging Markets
China

With 135 pages, 154 charts and eight chapters, to display the market present situation and future, clearly and deeply.



Please Select Format

Enquiry About Report

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

Global General Medicine Education Publishing Market (Type, Geography) Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Opportunities, Segmentation, Forecast (2013-2020)

General medicine is a branch of medicine that deals with diagnosis and treatment of diseases associated with internal organs. It is also called as Internal Medicine. General medicine education market has shown substantial growth due to the adoption of internal medicine as a career option by medical students.

January 2018| $5370 | Pre Book Price:$4699

Cancer Vaccine Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015- 2024

Cancer vaccines are biological response modifiers. These vaccines work by stimulating or restoring the immune system�s ability to fight against infections and diseases. It is used either as stand-alone therapies ...

January 2018| $4995 | Pre Book Price:$4371

World Active Pharmaceutical Ingredient (API) Market - Opportunities and Forecasts, 2014 - 2020

Increase in Abbreviated New Drug Applications (ANDA) over the past years has fostered the demand for API market. Furthermore, Indian companies making increased entries related to Drug Master File (DMF) ...

January 2018| $5370 | Pre Book Price:$4699

Anterior Uveitis Asia-Pacific Market Research Report, 2014 - 2020

Anterior uveitis is an eye inflammation that involves middle layer of the eye specifically, iris (colored part of the eye) and ciliary body (adjacent tissue). Untreated anterior uveitis results in ...

January 2018| $2850 | Pre Book Price:$2494

Nanomedicine Asia-Pacific Market Research Report, 2014 - 2020

Nanomedicine is the applied branch of nanotechnology. Application of nanomedicines ranges from nonmaterial to nanoelectronic and in the near future, it could possibly expand to molecular nanotechnology. Biological, pharmaceutical and ...

January 2018| $2850 | Pre Book Price:$2494

Autoimmune Disorders Treatment Asia-Pacific Market Research Report, 2014 - 2020

Graves disease, Multiple sclerosis, Myasthenia gravis, Rheumatoid arthritis, Pernicious anemia and Systemic lupus erythematosus are the most prevalent types of autoimmune disorders. The prevalence of autoimmune diseases is high in ...

January 2018| $2850 | Pre Book Price:$2494

2018 © Copyright Big Market Research

View Pricing >>